[128] In contrast, other DAT inhibitors which include bupropion have not been observed to exhibit this outcome.[129] These observations have prompted the speculation that methylphenidate may possibly work as a "DAT inverse agonist" or "destructive allosteric modifier from the DAT" by reversing the route on the dopamine efflux with the DAT at greate